Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iftekhar Mahmood

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Journal of Clinical Pharmacology|June 29, 2021
Spreadsheet-Based Minimal Physiological Models for the Prediction of Clearance of Therapeutic Proteins in Pediatric PatientsIftekhar Mahmood, Million A Tegenge
Drug Metabolism and Drug Interactions|October 12, 2013
A population pharmacokinetic model of remifentanil in pediatric patients using body-weight-dependent allometric exponentsCarl-Michael Staschen, Iftekhar Mahmood
International Immunopharmacology|March 6, 2020
Considerations for pharmacokinetic assessment of immunoglobulins: Gammagard in very low birth weight neonates with and without baseline-correctionIftekhar Mahmood, Million A Tegenge, Basil Golding
The AAPS Journal|October 3, 2014
Prediction of drug clearance in children: an evaluation of the predictive performance of several modelsIftekhar Mahmood, Carl-Michael Staschen, Kosalaram Goteti
Journal of Pharmaceutical Sciences|October 15, 2009
Prediction of human drug clearance from two species: a comparison of several allometric methodsKosalaram Goteti, C Edwin Garner, Iftekhar Mahmood
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 28, 2019
Clinical Pharmacology Review of Plasma-derived and Recombinant Protein Products: CBER Experience and Perspectives on Model-Informed Drug DevelopmentMillion A Tegenge, Iftekhar Mahmood, Richard Forshee
Antibodies (Basel, Switzerland)|June 25, 2020
Considerations for Optimizing Dosing of Immunoglobulins Based on Pharmacokinetic EvidenceIftekhar Mahmood, Million A Tegenge, Basil Golding
European Journal of Drug Metabolism and Pharmacokinetics|November 9, 2015
Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling MethodsIftekhar Mahmood, Anna Cheng, Edward Brauer, et al.
Journal of Clinical Pharmacology|July 17, 2003
Selection of the first-time dose in humans: comparison of different approaches based on interspecies scaling of clearanceIftekhar Mahmood, Martin David Green, J Edward Fisher
Drugs in R&D|December 1, 2020
Dosing Considerations for Antibodies Against COVID-19Million A Tegenge, Iftekhar Mahmood, Evi Struble, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of Clinical Pharmacology|June 29, 2021
Spreadsheet-Based Minimal Physiological Models for the Prediction of Clearance of Therapeutic Proteins in Pediatric PatientsIftekhar Mahmood, Million A Tegenge
Drug Metabolism and Drug Interactions|October 12, 2013
A population pharmacokinetic model of remifentanil in pediatric patients using body-weight-dependent allometric exponentsCarl-Michael Staschen, Iftekhar Mahmood
International Immunopharmacology|March 6, 2020
Considerations for pharmacokinetic assessment of immunoglobulins: Gammagard in very low birth weight neonates with and without baseline-correctionIftekhar Mahmood, Million A Tegenge, Basil Golding
The AAPS Journal|October 3, 2014
Prediction of drug clearance in children: an evaluation of the predictive performance of several modelsIftekhar Mahmood, Carl-Michael Staschen, Kosalaram Goteti
Journal of Pharmaceutical Sciences|October 15, 2009
Prediction of human drug clearance from two species: a comparison of several allometric methodsKosalaram Goteti, C Edwin Garner, Iftekhar Mahmood
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 28, 2019
Clinical Pharmacology Review of Plasma-derived and Recombinant Protein Products: CBER Experience and Perspectives on Model-Informed Drug DevelopmentMillion A Tegenge, Iftekhar Mahmood, Richard Forshee
Antibodies (Basel, Switzerland)|June 25, 2020
Considerations for Optimizing Dosing of Immunoglobulins Based on Pharmacokinetic EvidenceIftekhar Mahmood, Million A Tegenge, Basil Golding
European Journal of Drug Metabolism and Pharmacokinetics|November 9, 2015
Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling MethodsIftekhar Mahmood, Anna Cheng, Edward Brauer, et al.
Journal of Clinical Pharmacology|July 17, 2003
Selection of the first-time dose in humans: comparison of different approaches based on interspecies scaling of clearanceIftekhar Mahmood, Martin David Green, J Edward Fisher
Drugs in R&D|December 1, 2020
Dosing Considerations for Antibodies Against COVID-19Million A Tegenge, Iftekhar Mahmood, Evi Struble, et al.
Pageof 9